x

Search for a diagnostic test

* (*) mandatory field

116 Result(s)

Filter by

Speciality(ies)/objective(s)

Technique(s)

Purpose(s)

Quality management

Country(ies)

Reset
Sort by

Caption : Accreditation =Accreditation ;

GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation Analysis of susceptibility for narcolepsy (HLA-DQB1, HLA-DRB1)
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation Risk calculation on molecular basis for celiac disease (HLA-DQA1, HLA-DQB1)
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
GERMANY

Bayern
MÜNCHEN

Accreditation HLA-genotyping: susceptibility for narcolepsy - testing of DR15 DQB1*0602
Medizinisch Genetisches Zentrum München
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of susceptibility to celiac disease (HLA-DQB1 gene)
CHU Paris - Hôpital Robert Debré
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

PAYS DE LA LOIRE
NANTES

Accreditation HLA-DRB1 and HLA-DQB1 genotyping by PCR SSP or PCR SSO
Etablissement Français du Sang Centre - Pays de Loire
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
SWITZERLAND

Suisse Romande
SION

Accreditation Diagnosis of susceptibility to celiac disease (HLA-DQ2 and HLA-DQ8 alleles)
Institut Central des Hôpitaux (ICH)
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
UNITED KINGDOM

Greater London
LONDON

Accreditation Molecular diagnosis of susceptibility to celiac disease (HLA-DQ2 and HLA-DQ8 associated alleles)
The Doctors Laboratory Ltd
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
UNITED KINGDOM

Greater London
LONDON

Accreditation Analysis of susceptibility for narcolepsy (HLA-DQB1*15, HLA-DRB1*06)
The Doctors Laboratory Ltd
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
FRANCE

HAUTS-DE-FRANCE
LILLE

Accreditation Diagnosis of susceptibility to celiac disease (genotyping of HLA-DQA1 and HLA-DQB1 by PCR-SSO)
CHU de Lille - Centre de Biologie Pathologie Génétique
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

HAUTS-DE-FRANCE
LILLE

Accreditation Diagnosis of susceptibility to rare insulin-dependent diabetes mellitus (HLA-DQA1, HLA-DQB1 and HLA-DRB1 genotyping by PCR-SSO)
CHU de Lille - Centre de Biologie Pathologie Génétique
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

HAUTS-DE-FRANCE
LILLE

Accreditation Diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1 genotyping)
CHU de Lille - Centre de Biologie Pathologie Génétique
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of susceptibility to narcolepsy with cataplexy (HLA-DQB1 gene)
AP-HP.Sorbonne Université - Hôpital de la Pitié-Salpêtrière
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
DÉCINES CHARPIEU

Accreditation Diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1, HLA-DRB1 genes)
Établissement Français du Sang - Auvergne Rhône-Alpes
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
DÉCINES CHARPIEU

Accreditation Diagnosis of susceptibility to diabetes (HLA-DQA1, -DQB1 and -DRB1 genes)
Établissement Français du Sang - Auvergne Rhône-Alpes
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
DÉCINES CHARPIEU

Accreditation Diagnosis of susceptibility to celiac disease (HLA-DQA1 and -DQB1 genes)
Établissement Français du Sang - Auvergne Rhône-Alpes
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
SWITZERLAND

Suisse Alémanique
ZÜRICH

Accreditation Diagnosis of susceptibility to celiac disease (HLA DQA1 and HLA DQB1 genes)
Institut für Medizinische & Molekulare Diagnostik
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1 gene)
CHU Paris - Hôpital Robert Debré
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

ILE-DE-FRANCE
SAINT-OUEN-L'AUMÔNE

Accreditation Diagnosis of susceptibility to celiac disease (HLA-DQB1 genotyping)
Laboratoire Cerba
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
ITALY

VENETO
PADOVA

Accreditation Molecular diagnosis of predisposition of celiac disease (HLA-DQ*2/DQ*8 gene)
Azienda Ospedaliera di Padova
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
FRANCE

BRETAGNE
BREST

Accreditation Diagnosis of predisposition to celiac disease (HLA-DQB1 gene)
CHU de Brest - Hôpital de la Cavale Blanche
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
LA TRONCHE

Accreditation Diagnostic de susceptibilité au diabète sucré type 1 (gènes HLA-DQA1, HLA-DQB1, HLA-DRB1 : PCR-SSO)
Établissement Français du Sang - Rhône Alpes - Grenoble
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
LA TRONCHE

Accreditation Diagnosis of susceptibility to celiac disease (HLA-DQA1 and -DQB1 genes: PCR-SSO)
Établissement Français du Sang - Rhône Alpes - Grenoble
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
LA TRONCHE

Accreditation Diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1, HLA-DRB1 genes: PCR-SSO)
Établissement Français du Sang - Rhône Alpes - Grenoble
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
GERMANY

Bayern
MARTINSRIED/PLANEGG

Accreditation Risk calculation on molecular basis for celiac disease (HLA-DRB1, HLA-DQA1, HLA-DQB1)
MVZ Martinsried GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
FRANCE

BRETAGNE
RENNES

Accreditation Diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1)
Établissement Français du Sang - Bretagne
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), PCR based techniques

More information
FRANCE

BRETAGNE
RENNES

Accreditation Diagnosis of susceptibility to diabetes mellitus type 1 (gènes HLA-DRB1, HLA-DQA1, HLA-DQB1)
Établissement Français du Sang - Bretagne
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

BRETAGNE
RENNES

Accreditation Diagnosis of susceptibility to celiac disease (HLA-DQA1 and HLA-DQB1 genes)
Établissement Français du Sang - Bretagne
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), PCR based techniques

More information
SWITZERLAND

Suisse Romande
LAUSANNE

Accreditation Diagnosis of susceptibility to celiac disease (HLA-DQA1, HLA-DQB1)
Synlab Lausanne
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Risk calculation on molecular basis for celiac disease (HLA-DQ2 and HLA-DQ8)
Zweigniederlassung der SYNLAB MVZ Augsburg GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

ILE-DE-FRANCE
SAINT-OUEN-L'AUMÔNE

Accreditation Diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 genotyping)
Laboratoire Cerba
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

PAYS DE LA LOIRE
ANGERS

Accreditation Diagnosis of susceptibility to celiac disease (HLA-DQB1 gene)
Établissement Français du Sang - Angers
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

Accreditation Diagnosis of susceptibility to celiac disease (HLA-DQA1 and HLA-DQB1 genes)
Établissement Français du Sang - Bourgogne/Franche-Comté
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
LYON

Accreditation Diagnosis of susceptibility to celiac disease (HLA-DQB1 and HLA-DRB1 genotyping)
Eurofins Biomnis
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
LYON

Accreditation HLA-DRB1 and HLA-DQB1 genotyping by PCR SSP or PCR SSO
Laboratoire Alpigene
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

GRAND-EST
STRASBOURG

Accreditation Diagnosis of susceptibility to celiac disease (HLA-DQA1 and HLA-DQB1 genes)
Établissement Français du Sang - Grand Est
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

GRAND-EST
STRASBOURG

Accreditation Diagnosis of susceptibility to rheumatoid arthritis (HLA-DRB1 and HLA-DQB1 genes)
Établissement Français du Sang - Grand Est
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

GRAND-EST
STRASBOURG

Accreditation Diagnosis of susceptibility to diabetes mellitus type 1 (gènes HLA-DQB1 and HLA-DRB1)
Établissement Français du Sang - Grand Est
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

PAYS DE LA LOIRE
ANGERS

Accreditation Diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 gene)
Établissement Français du Sang - Angers
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

PAYS DE LA LOIRE
ANGERS

Accreditation Diagnostic de susceptibilité au diabète sucré type 1 (gènes HLA-DRB1 ; HLA-DQB1)
Établissement Français du Sang - Angers
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

Accreditation Diagnosis of susceptibility to narcolepsy with cataplexy (HLA-DQB1*06:02 gene)
Établissement Français du Sang - Bourgogne/Franche-Comté
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

Accreditation Diagnosis of susceptibility to rheumatoid arthritis (HLA-DRB1 genotyping)
Établissement Français du Sang - Bourgogne/Franche-Comté
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

Accreditation Diagnosis of susceptibility to diabetus mellitus type 1 (genes HLA-DQB1, HLA-DRB1, HLA-DQA1)
Établissement Français du Sang - Bourgogne/Franche-Comté
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation Molecular analysis of somatic mutation in tumour tissue for therapeutic decisions (Somatic Tumor Panel, 710 genes)
CeGaT GmbH
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Analysis of susceptibility for narcolepsy (HLA-DQB1, HLA-DRB1)
Zweigniederlassung der SYNLAB MVZ Augsburg GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

NOUVELLE AQUITAINE
POITIERS

Accreditation Diagnosis of susceptibility to celiac disease (HLA-DQB1 gene)
Établissement Français du Sang - Poitiers
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES), PCR based techniques

More information
FRANCE

NOUVELLE AQUITAINE
POITIERS

Accreditation Diagnosis of susceptibility to narcolepsy-cataplexy syndrome (HLA-DQB1 gene)
Établissement Français du Sang - Poitiers
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES), PCR based techniques

More information
FRANCE

BRETAGNE
BREST

Accreditation Diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1 gene)
CHU de Brest - Hôpital de la Cavale Blanche
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

CENTRE-VAL DE LOIRE
TOURS

Accreditation Diagnosis of predisposition to narcolepsy type 1 (HLA-DQB1*06:02 gene)
Établissement Français du Sang - Centre Pays de la Loire
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

CENTRE-VAL DE LOIRE
TOURS

Accreditation Diagnosis of susceptibility to celiac disease (HLA-DQB1 gene)
Établissement Français du Sang - Centre Pays de la Loire
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

CENTRE-VAL DE LOIRE
TOURS

Accreditation Diagnostic de susceptibilité au diabète type 1 (gènes HLA-DQB1 et HLA-DRB1)
Établissement Français du Sang - Centre Pays de la Loire
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND

Accreditation Diagnosis of susceptibility to narcolepsy syndrome (HLA-DQB1 gene)
CHU de Clermont-Ferrand - Hôpital Gabriel Montpied
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND

Accreditation Diagnosis of predisposition to celiac disease (HLA-DQB1 gene)
CHU de Clermont-Ferrand - Hôpital Gabriel Montpied
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
BELGIUM

VLAAMS BRABANT
LEUVEN

Accreditation Diagnosis of narcolepsy with or without cataplexy (HLA-DQB1 gene)
UZ Leuven - Campus Gasthuisberg
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

Accreditation Diagnosis of HLA related diseases (HLA typing)
Etablissement Français de Sang
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES), PCR based techniques

More information
FRANCE

NORMANDIE
BOIS GUILLAUME

Accreditation Diagnosis of HLA related diseases (HLA typing)
EFS HFNO
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES), PCR based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnostic de susceptibilité au diabète type 1 (gènes HLA-DQB1 et HLA-DRB1)
AP-HP.Sorbonne Université - Hôpital de la Pitié-Salpêtrière
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of susceptibility to celiac disease (HLA-DQA1 and HLA-DQB1 gene)
AP-HP.Sorbonne Université - Hôpital de la Pitié-Salpêtrière
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
BELGIUM

VLAAMS BRABANT
LEUVEN

Accreditation Diagnosis of susceptibility to celiac disease (HLA-DQ2 and HLA-DQ8 alleles)
UZ Leuven - Campus Gasthuisberg
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
GERMANY

Baden-Württemberg
SINGEN /HTWL.

Accreditation Risk calculation on molecular basis for celiac disease (HLA-DQ2 and HLA-DQ8)
MVZ Laborärzte Singen GbR
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
GERMANY

Nordrhein-Westfalen
BAD OEYNHAUSEN

Accreditation Analysis of susceptibility for narcolepsy (HLA-DQ, HLA-DR)
Ruhr-Universität Bochum
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
GERMANY

Baden-Württemberg
STUTTGART

Accreditation Risk calculation on molecular basis for celiac disease (HLA-DQ locus)
Labor Prof. Dr. G. Enders MVZ
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
ITALY

SICILIA
CATANIA

Accreditation Molecular diagnosis of predisposition of celiac disease (HLA-DQ*2/DQ*8 gene)
LABOGEN S.a.S.
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
SWITZERLAND

Suisse Romande
GENÈVE

Accreditation Molecular diagnosis of susceptibilty to narcolepsy with or without cataplexy (HLA-DQB1 gene)
Hôpitaux Universitaires de Genève HUG
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
GERMANY

Bayern
BAD STEBEN

Risk calculation on molecular basis for celiac disease (HLA-DQ locus)
Institut für angewandte Humangenetik und Onkogenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

LOMBARDIA
MONZA

Diagnosis of celiac disease susceptibility (HLA-DQA and HLA-DQB genes)
Synlab ITALIA srl
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Nordrhein-Westfalen
KÖLN

Analysis of susceptibility for narcolepsy (HLA-DQB1, HLA-DRB1)
Zotz|Klimas Standort Köln
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
GERMANY

Nordrhein-Westfalen
KÖLN

Diagnosis of susceptibility to celiac disease (HLA-DRB1, HLA-DQB1)
Zotz|Klimas Standort Köln
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
GERMANY

Sachsen
DRESDEN

Analysis of susceptibility for narcolepsy (HLA-DQB1, HCRT, MOG genes)
Gemeinschaftspraxis für Humangenetik
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
ITALY

LAZIO
ROMA

Molecular diagnosis of suceptibility to celiac disease (HLA-DQA1, HLA-DQB1 genes)
Azienda Ospedaliera S. Camillo-Forlanini - Ospedale San Camillo
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

LAZIO
ROMA

Molecular diagnosis of suceptibility to narcolepsy (HLA-DQA1, HLA-DQB1 genes)
Azienda Ospedaliera S. Camillo-Forlanini - Ospedale San Camillo
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

TOSCANA
PRATO

Molecular diagnosis of susceptibility to celiac disease (HLA-DQA1, HLA-DQB1 genes)
USL4 - Nuovo Ospedale Santo Stefano
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
ITALY

TOSCANA
PRATO

Molecular diagnosis of susceptibility to narcolepsy (HAL-DQB1 gene)
USL4 - Nuovo Ospedale Santo Stefano
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
ITALY

CAMPANIA
NAPOLI

Diagnosis of susceptibility to celiac disease (HLA-DQB1, HLA-DQA1)
Biotecnologie Avanzate Srl
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
FRANCE

NOUVELLE AQUITAINE
LIMOGES

Diagnosis of susceptibility to celiac disease (HLA-DQB1 gene ; PCR-SSo high definition)
CHU de Limoges - Hôpital Dupuytren
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

NOUVELLE AQUITAINE
LIMOGES

Diagnosis of susceptibility to narcolepsy without cataplexy (HLA-DQB1 gene ; PCR-SSO)
CHU de Limoges - Hôpital Dupuytren
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

PROVENCE-ALPES-COTE D'AZUR
NICE

Diagnosis of susceptibility to narcolepsy with cataplexy (HLA-DQB1 and HLA-DRB1 genotyping)
CHU de Nice - Hôpital l'Archet 1
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

PROVENCE-ALPES-COTE D'AZUR
NICE

Diagnosis of susceptibility to diabetes mellitus type 1 (génotypage HLA-DQA1, HLA-DQB1 et HLA-DRB1)
CHU de Nice - Hôpital l'Archet 1
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

PROVENCE-ALPES-COTE D'AZUR
NICE

Diagnosis of susceptibility to multiple sclerosis (HLA-DRB1 genotyping)
CHU de Nice - Hôpital l'Archet 1
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

PROVENCE-ALPES-COTE D'AZUR
NICE

Diagnosis of susceptibility to celiac disease (HLA-DRB1 genotyping)
CHU de Nice - Hôpital l'Archet 1
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

NOUVELLE AQUITAINE
BORDEAUX

Diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 genotyping)
CHU de Bordeaux-GH Pellegrin
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

NOUVELLE AQUITAINE
BORDEAUX

Diagnosis of susceptibility to diabetes mellitus type 1 (genotyping HLA-DRB1, HLA-DQA1, HLA-DQB1)
CHU de Bordeaux-GH Pellegrin
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

NOUVELLE AQUITAINE
BORDEAUX

Diagnosis of susceptibility to celiac disease (HLA-DQA1 and HLA-DQB1 genotyping)
CHU de Bordeaux-GH Pellegrin
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Diagnosis of susceptibility to celiac disease (HLA-DQB1 gene ; PCR-SSO)
GHU AP-HP Nord. Université de Paris - Hôpital Saint-Louis
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 gene ; PCR-SSO)
GHU AP-HP Nord. Université de Paris - Hôpital Saint-Louis
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
ITALY

SICILIA
AVOLA

Diagnosis of predisposition of celiac disease (HLA-DQ*2/DQ*8 gene)
Laboratori Campisi s.r.l.
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

GRAND-EST
REIMS

Diagnosis of susceptibility to diabetus mellitus type 1 (gene HLA-DQB1, HLA-DRB1, HLA-DQA1)
CHU de Reims - Hôpital Robert Debré
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

GRAND-EST
REIMS

Diagnosis of predisposition to celiac disease (HLA-DQA1, HLA-DQB1 gene)
CHU de Reims - Hôpital Robert Debré
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

GRAND-EST
REIMS

Diagnosis of predisposition to narcolepsy-cataplexy (HLA-DQB1*06:02 gene)
CHU de Reims - Hôpital Robert Debré
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Diagnosis of susceptibility to diabetes mellitus type 1 (gène HLA-DQB1 : PCR-SSO)
GHU AP-HP Nord. Université de Paris - Hôpital Saint-Louis
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
GERMANY

Sachsen
DRESDEN

Risk calculation on molecular basis for celiac disease (HLA-DQ2 and HLA-DQ8)
Gemeinschaftspraxis für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

MOLISE
POZZILLI

Molecular diagnosis of susceptibility to celiac disease (HLADQA1, HLADRB1, HLADQB1 genes)
Istituto Neurologico Mediterraneo - IRCCS Neuromed
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
ITALY

BASILICATA
MATERA

Postnatal molecular diagnosis for genetic predisposition to celiac disease (HLA-DQ*2/DQ*8)
Presidio Ospedaliero "Madonna delle Grazie" - Azienda Sanitaria di Matera (ASM)
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
ITALY

VENETO
LIMENA

Molecular diagnosis of genetic susceptibility to celiac disease (HLA Locus)
RDI - RETE DIAGNOSTICA ITALIANA
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
FRANCE

OCCITANIE
TOULOUSE

Diagnosis of susceptibility to celiac disease (HLA-DQB1, HLA-DQA1 and HLA-DRB1 genotyping)
CHU de Toulouse - Hôpital Purpan
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
SWITZERLAND

Suisse Romande
LAUSANNE

Diagnosis of susceptibility to celiac disease (HLA DQA1 and HLA DQB1 genes)
Gene Predictis SA
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
SPAIN

Madrid
MADRID

Diagnosis of monogenic disease with epilepsy (panel)
Hospital Universitario Fundación Jiménez Díaz
Purpose(s) : Antenatal diagnosis, Pre-implantation diagnosis, Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Madrid
MADRID

Diagnosis of epilepsy syndrome (panel)
Hospital Universitario Fundación Jiménez Díaz
Purpose(s) : Antenatal diagnosis, Pre-implantation diagnosis, Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of vasculopathy (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
ITALY

EMILIA ROMAGNA
FERRARA

Diagnosis of susceptibility to celiac disease (HLA-DQA1, HLA-DQB1 genes)
A.O.U. Sant'Anna - Polo Chimico-Bio-Medico
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
ITALY

EMILIA ROMAGNA
FERRARA

Diagnosis of susceptibility to diabetes mellitus type 1 (HLA-DQB1, HLA-DRB1 genes)
A.O.U. Sant'Anna - Polo Chimico-Bio-Medico
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
ITALY

EMILIA ROMAGNA
FERRARA

Diagnosis of narcolepsy types 1 and 2 (HLA-DQB1, HLA-DRB1 genes)
A.O.U. Sant'Anna - Polo Chimico-Bio-Medico
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
SPAIN

País Vasco
SAN SEBASTIÁN

Diagnosis of narcolepsy (panel)
DNA Data
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

OCCITANIE
TOULOUSE

Diagnosis of predisposition to narcolepsy type 1 (HLA-DQB1*06:02 gene)
CHU de Toulouse - Hôpital Purpan
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

OCCITANIE
TOULOUSE

Diagnostic de susceptibilité au diabète sucré type 1 (gènes HLA-DQA1 ; HLA-DRB1 ; HLA-DQB1)
CHU de Toulouse - Hôpital Purpan
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

More information
ITALY

CAMPANIA
AVELLINO

Molecular diagnosis of susceptibility to celiac disease (DQA1 and DQB1 genes)
Azienda Ospedaliera San Giuseppe Moscati
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
ITALY

PUGLIA
LECCE

Molecular diagnosis of susceptibility to celiac disease (HLADQA1, HLADRB1, HLADQB1 genes)
Presidio Ospedaliero "Vito Fazzi" - ASL LE
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
ITALY

PUGLIA
SAN GIOVANNI ROTONDO

Molecular diagnosis of susceptibility to celiac disease (HLA-DQA1, HLA-DQB1 genes)
Fondazione IRCCS Ospedale Casa Sollievo della Sofferenza
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
ITALY

LOMBARDIA
LODI

Molecular diagnosis of susceptibility to celiac disease (DQB1 gene)
Azienda Ospedaliera della Provincia di Lodi
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
ITALY

LOMBARDIA
BRESCIA

Molecular diagnosis of susceptibility to celiac disease (DQA1 and DQB1 genes)
Biodiversity
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
CZECH REPUBLIC

Moravia-Silesia
OSTRAVA

Molecular diagnosis of susceptibility to celiac disease (HLA-DQA1 and HLA-DQB1 genes)
CGB laboratory Ltd.
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
ITALY

LAZIO
ROMA

Molecular diagnosis of predisposition to celiac disease (HLA-DQ*2/DQ*8 gene)
USI - Unione Sanitaria Internazionale
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
ITALY

SICILIA
SIRACUSA

Molecular diagnosis of susceptibility to celiac disease (HLA-DQ2, HLA-DQ8, HLA-DR genes)
Centro Analisi Cliniche
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
PORTUGAL

CENTRO
OEIRAS

Analysis of susceptibility for Narcolepsy-cataplexy and Narcolepsy without cataplexy (HLA-DQB1 and HLA-DRB1 gene)
Laboratório de Análises Clínicas Dr. Joaquim Chaves
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
PORTUGAL

CENTRO
OEIRAS

Analysis of susceptibility for Celiac disease (HLA-DQA1, HLA-DQB1 genes)
Laboratório de Análises Clínicas Dr. Joaquim Chaves
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
PORTUGAL

ILHAS
FUNCHAL

Molecular diagnosis of susceptibility to celiac disease (HLA-DQA1, HLA-DQB1 genes: sequencing of exon 2)
Universidade da Madeira
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
ITALY

EMILIA ROMAGNA
BOLOGNA

Molecular diagnosis of susceptibility to celiac disease (HLA-DQA1, HLA-DQB1 genes determined by Real Time PCR)
NGB Genetics Srl
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Technique(s) : PCR based techniques

More information